Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gee

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Archives Italiennes De Biologie|December 24, 2010
Data warehousing methods and processing infrastructure for brain recovery researchT Gee, S Kenny, C J Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Lymphoblastic lymphoma in adultsD E Slater, R Mertelsmann, B Koziner, et al.
Methods (San Diego, Calif.)|June 25, 2013
Adoption of the Q transcriptional regulatory system for zebrafish transgenesisAbhignya Subedi, Michelle Macurak, Stephen T Gee, et al.
Suicide & Life-Threatening Behavior|November 5, 2016
A Machine Learning Approach to Identifying the Thought Markers of Suicidal Subjects: A Prospective Multicenter TrialJohn P Pestian, Michael Sorter, Brian Connolly, et al.
Leukemia|February 1, 1989
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocolE Berman, Z A Arlin, J Gaynor, et al.
Seminars in Oncology|February 1, 1989
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer CenterE Berman, V Raymond, T Gee, et al.
Blood|April 1, 1980
Heterogeneity of cell lineages in L3 leukemiasB Koziner, R Mertelsmann, M Andreeff, et al.
Seminars in Oncology|June 1, 1992
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemiaJ E Kolitz, S J Kempin, A Schluger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemiaZ A Arlin, R Mertelsmann, E Berman, et al.
Nature Protocols|July 15, 2016
Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessmentClifford T Gee, Keith E Arntson, Andrew K Urick, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Archives Italiennes De Biologie|December 24, 2010
Data warehousing methods and processing infrastructure for brain recovery researchT Gee, S Kenny, C J Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Lymphoblastic lymphoma in adultsD E Slater, R Mertelsmann, B Koziner, et al.
Methods (San Diego, Calif.)|June 25, 2013
Adoption of the Q transcriptional regulatory system for zebrafish transgenesisAbhignya Subedi, Michelle Macurak, Stephen T Gee, et al.
Suicide & Life-Threatening Behavior|November 5, 2016
A Machine Learning Approach to Identifying the Thought Markers of Suicidal Subjects: A Prospective Multicenter TrialJohn P Pestian, Michael Sorter, Brian Connolly, et al.
Leukemia|February 1, 1989
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocolE Berman, Z A Arlin, J Gaynor, et al.
Seminars in Oncology|February 1, 1989
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer CenterE Berman, V Raymond, T Gee, et al.
Blood|April 1, 1980
Heterogeneity of cell lineages in L3 leukemiasB Koziner, R Mertelsmann, M Andreeff, et al.
Seminars in Oncology|June 1, 1992
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemiaJ E Kolitz, S J Kempin, A Schluger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemiaZ A Arlin, R Mertelsmann, E Berman, et al.
Nature Protocols|July 15, 2016
Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessmentClifford T Gee, Keith E Arntson, Andrew K Urick, et al.
Pageof 13